Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.
about
Diagnostic and therapeutic applications of lytic phagesExperimental phage therapy against Staphylococcus aureus in miceEcology of Anti-Biofilm Agents I: Antibiotics versus BacteriophagesMycobacteriophages: windows into tuberculosisMycobacteriophage and their application to disease controlTrypanosoma cruzi Differentiates and Multiplies within Chimeric Parasitophorous Vacuoles in Macrophages Coinfected with Leishmania amazonensis.Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.Molecular Genetics of Mycobacteriophages.In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.The pathogenesis, detection, and prevention of Vibrio parahaemolyticus.Population and evolutionary dynamics of phage therapy.Impact of relative humidity and collection media on mycobacteriophage D29 aerosol.Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Experimental Phage Therapy for Burkholderia pseudomallei InfectionLearning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Microneedle-mediated transdermal bacteriophage delivery.Intracellular Staphylococcus aureus Control by Virulent Bacteriophages within MAC-T Bovine Mammary Epithelial Cells.A first step toward liposome-mediated intracellular bacteriophage therapy.Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.Active and adaptive Legionella CRISPR-Cas reveals a recurrent challenge to the pathogen.Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1.Targeting the gut to protect the bladder: Oral Phage therapy approaches against urinary Escherichia coli infections?Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host LethalityStudies of the efficacy of Enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice.Titer dynamic analysis of D29 within MTB-infected macrophages and effect on immune function of macrophages.Influence of bacteriophage P22 on the inflammatory mediator gene expression in chicken macrophage HD11 cells infected with Salmonella Typhimurium.Expression and purification of recombinant lyase gp17 from the LSB-1 phage in Escherichia coli.Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Antimycobacterial activity of fruit of DC againstNanoencapsulation of Bacteriophages in Liposomes Prepared Using Microfluidic Hydrodynamic Flow Focusing
P2860
Q23920569-C9386FD1-C1AE-4582-A329-5785ABF5E173Q24685170-F703A425-DB03-43FA-91FC-9CD834133860Q26786950-F7477F13-1F3B-4B79-BFBA-C7FAFD3FA87FQ28236396-BD5B6FD6-1ED0-4F55-AFDD-754F675E164FQ28262790-A4140F8C-70F4-4609-AF0B-000FA1834C69Q30755649-2A0279E7-748F-4ED1-8947-94526701A4DEQ33622945-606FCCEB-A366-464F-B249-0E538625E7EFQ33850107-0C91C992-DC0A-4858-9F27-C310D7D24AA9Q34349353-8C657D58-7C3A-4F77-BCCA-9A80E79B6500Q35124495-A56F60EE-BDB9-4971-845D-B2C60C97CCCDQ35149904-4CC3692C-EF07-4C78-B193-73194752EF45Q35709197-28797A79-1E89-4589-91F7-CF05B10A17EEQ35804826-BEC262E6-158B-4D75-938E-DD228C018A55Q35963673-1E970671-7D45-4B2A-8F64-000305D937ECQ36069790-AA02D419-13A4-4627-93E7-77E30DE52A36Q36676044-89EF7893-EAF6-4CAD-8B15-C4C112A17C00Q37187438-388AD36F-DDBE-44F4-9D1A-551B60AA0119Q37612917-F67BB681-6962-46EA-BA5C-1769F411A4B8Q38879534-CCDCDA49-2C5F-4F18-A25F-E5E9AA1684BCQ39906833-646C4E33-C832-4325-9FCA-F89D678FEFA4Q39952605-C1658E05-02FB-4B2A-AE1C-3E3BCC3320CDQ40387314-7D7A094B-7F97-4476-A42D-9C4CBC531D5AQ40722466-E551467A-9B09-4EEE-9F19-C95665481D82Q40948487-1CB216B5-17C6-490C-821E-FB2CC8134627Q41457775-231444EC-5734-4C8A-ACE0-5F26BCAC4D9CQ42242159-AD9FCA39-486E-4157-BDE3-BBEBE39F174EQ45001310-93134C70-F480-4038-B92B-574FBBB8F66BQ45017741-729EF02A-6A41-44EF-9015-54D637F7EBF6Q48293875-C36A1D19-493D-4800-A3D7-95EEA5463B2EQ49631079-D3522DAA-E006-49DB-A4F5-3687EFDBB68AQ57822575-634C3B05-F008-4C79-A8A9-7E7BD0D97443Q57929262-A25CAA39-4D96-4654-95DE-97EAE311F76E
P2860
Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Killing of Mycobacterium avium ...... acellular bacterial pathogens.
@en
type
label
Killing of Mycobacterium avium ...... acellular bacterial pathogens.
@en
prefLabel
Killing of Mycobacterium avium ...... acellular bacterial pathogens.
@en
P2093
P356
P1476
Killing of Mycobacterium avium ...... acellular bacterial pathogens.
@en
P2093
Danuta Sosnowska
Dirk Wagner
Elizabeth Miltner
Lawrence Broxmeyer
Luiz E Bermudez
Ofelia Chacón
Raúl G Barletta
P304
P356
10.1086/343812
P407
P577
2002-09-30T00:00:00Z